Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    • News

  • Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    • News

  • Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    • News

  • European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    • News

  • Harris Technology’s refurbished boom signals FY26 profit inflection
    Harris Technology’s refurbished boom signals FY26 profit inflection
    • News

Innodata pulls bid after Appen is forced to breach confidential details to ASX

  • In News
  • March 14, 2024
  • Alinda Gupta
Innodata pulls bid after Appen is forced to breach confidential details to ASX

After having its contract with Google terminated, artificial intelligence company Appen (ASX: APX) has been kicked while down after getting trapped between rock and hard place, with leading data company Innodata to withdraw its takeover bid, citing a confidentiality breach.

On March 12, 2024, Appen received a letter from the ASX inquiring about its price and trading volume—its shares rallied 30% on the day, to which it promptly replied. In its response, Appen revealed that it had received a preliminary proposal from Innodata regarding a potential merger between the two companies, which was highly conditional, confidential, and non-binding. 

However, overnight, Innodata informed Appen that it was retracting its proposal because it was intended to remain confidential. In a press release, Innodata expounded, “The Proposal was made public by Appen on March 12, 2024, after the Australian Securities Exchange (ASX), at the request of Appen, halted trading in Appen stock and required disclosure of any business activities which impacted recent trading in Appen’s stock.”

Unfortunately, Appen had little say in the matter.

It was obligated to respond to the ASX letter highlighting a change in price in Appen’s securities from a low of $0.87 to a high of $1.11 and an increase in the volume of APX shares being traded. 

Appen noted that, in recent months, it has engaged in confidential discussions with various parties who have expressed an interest in some or all of Appen’s business. Other than an indicative proposal from Innodata, Inc, none of the discussions progressed to any indicative proposal being put to Appen. 

Innodata is a New Jersey-based NASDAQ-listed entity that proposed a potential combination of the two companies through a stock-for-stock transaction. The Indicative Proposal, worth $154 million, contemplated an offer consideration of $0.70 worth of Innodata shares per Appen share (which equated to a premium in excess of 100% to the Appen share price when the Indicative Proposal was provided). 

Appen is hitting wall after wall in its pursuit of cost efficiencies. This is not the first abrupt termination it has seen this year. In January, Google terminated its contract with Appen without notice. This was a huge financial blow since the tech giant was bringing in over $80 million in revenue for the Company. 

What’s more, this is the second time a takeover bid for Appen has been abruptly withdrawn over the past couple of years. Earlier, Canadian IT firm Telus had proposed a $1.2 billion takeover in mid-2022, but it abruptly withdrew its offer without offering a reason.

Even though AI reigns supreme in today’s tech environment (think ChatGPT, Gemini and much more), Appen has to grapple with more foundational issues. 

Its share price has gone from over $30 in 2020 to only about 14 cents now. APX shares plunged 40% on market open following the Google news announcement. This time around, however, shares fell by about 15%, with shareholders expressing sympathy for Appen. 

 

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  •  
  •  
  •  
  •  
  • ai
  • Appen
  • artificial intelligence
  • asx
  • asx ai
  • asx apx
  • chatgpt
  • Gemini
  • Innodata
  • Telus
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.